These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 27189330)

  • 1. Performance of Disease Risk Score Matching in Nested Case-Control Studies: A Simulation Study.
    Desai RJ; Glynn RJ; Wang S; Gagne JJ
    Am J Epidemiol; 2016 May; 183(10):949-57. PubMed ID: 27189330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the use and misuse of scalar scores of confounders in design and analysis of observational studies.
    Pfeiffer RM; Riedl R
    Stat Med; 2015 Aug; 34(18):2618-35. PubMed ID: 25781579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of disease risk scores, propensity scores, and traditional multivariable outcome regression in the presence of multiple confounders.
    Arbogast PG; Ray WA
    Am J Epidemiol; 2011 Sep; 174(5):613-20. PubMed ID: 21749976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
    Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
    Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Calipers for Matching on the Disease Risk Score.
    Connolly JG; Gagne JJ
    Am J Epidemiol; 2016 May; 183(10):937-48. PubMed ID: 27037270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of instrumental variable methods in cohort and nested case-control studies: a simulation study.
    Uddin MJ; Groenwold RH; de Boer A; Belitser SV; Roes KC; Hoes AW; Klungel OH
    Pharmacoepidemiol Drug Saf; 2014 Feb; 23(2):165-77. PubMed ID: 24306965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of propensity scores, disease risk scores, and regression in confounder adjustment for the safety of emerging treatment with group sequential monitoring.
    Xu S; Shetterly S; Cook AJ; Raebel MA; Goonesekera S; Shoaibi A; Roy J; Fireman B
    Pharmacoepidemiol Drug Saf; 2016 Apr; 25(4):453-61. PubMed ID: 26875591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One-to-many propensity score matching in cohort studies.
    Rassen JA; Shelat AA; Myers J; Glynn RJ; Rothman KJ; Schneeweiss S
    Pharmacoepidemiol Drug Saf; 2012 May; 21 Suppl 2():69-80. PubMed ID: 22552982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bias from matching on age at death or censor in nested case-control studies.
    Hein MJ; Deddens JA; Schubauer-Berigan MK
    Epidemiology; 2009 May; 20(3):330-8. PubMed ID: 19289956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving the efficiency of nested case-control studies of interaction by selecting controls using counter matching on exposure.
    Cologne JB; Sharp GB; Neriishi K; Verkasalo PK; Land CE; Nakachi K
    Int J Epidemiol; 2004 Jun; 33(3):485-92. PubMed ID: 15105408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A simulation study of control sampling methods for nested case-control studies of genetic and molecular biomarkers and prostate cancer progression.
    Wang MH; Shugart YY; Cole SR; Platz EA
    Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):706-11. PubMed ID: 19258478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extension of Disease Risk Score-Based Confounding Adjustments for Multiple Outcomes of Interest: An Empirical Evaluation.
    Desai RJ; Wyss R; Jin Y; Bohn J; Toh S; Cosgrove A; Kennedy A; Kim J; Kim C; Ouellet-Hellstrom R; Karami S; Major JM; Niman A; Wang SV; Gagne JJ
    Am J Epidemiol; 2018 Nov; 187(11):2439-2448. PubMed ID: 29947726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient risk set sampling when a time-dependent exposure is present: matching for time to exposure versus exposure density sampling.
    Wolkewitz M; Beyersmann J; Gastmeier P; Schumacher M
    Methods Inf Med; 2009; 48(5):438-43. PubMed ID: 19657545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of control selection in nested case-control studies: the example of exposure to antiretroviral treatment (ART) and the risk of myocardial infarction (MI) in the French Hospital Database on HIV (FHDH-ANRS CO4).
    Guiguet M; Mary-Krause M; Ename B; Costagliola D; Grabar S
    Pharmacoepidemiol Drug Saf; 2008 May; 17(5):468-74. PubMed ID: 18324608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Propensity-score-based Fine Stratification Approach for Confounding Adjustment When Exposure Is Infrequent.
    Desai RJ; Rothman KJ; Bateman BT; Hernandez-Diaz S; Huybrechts KF
    Epidemiology; 2017 Mar; 28(2):249-257. PubMed ID: 27922533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The "Dry-Run" Analysis: A Method for Evaluating Risk Scores for Confounding Control.
    Wyss R; Hansen BB; Ellis AR; Gagne JJ; Desai RJ; Glynn RJ; Stürmer T
    Am J Epidemiol; 2017 May; 185(9):842-852. PubMed ID: 28338910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An incidence density sampling program for nested case-control analyses.
    Richardson DB
    Occup Environ Med; 2004 Dec; 61(12):e59. PubMed ID: 15550597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential gain in precision and power by matching on strong risk factors in case-control studies: the example of laryngeal cancer.
    Stürmer T; Brenner H
    J Epidemiol Biostat; 2000; 5(2):125-31. PubMed ID: 10890284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjusting for Confounding in Early Postlaunch Settings: Going Beyond Logistic Regression Models.
    Schmidt AF; Klungel OH; Groenwold RH;
    Epidemiology; 2016 Jan; 27(1):133-42. PubMed ID: 26436519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of propensity score and disease risk score for multiple treatments with time-to-event outcome: a simulation study.
    Zhang D; Kim J
    J Biopharm Stat; 2019; 29(6):1103-1115. PubMed ID: 30831052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.